Pharmaceutical formulations of abiraterone acetate and niraparib

The present disclosure relates to a combination of abiraterone acetate and niraparib, free-dose and fixed-dose combinations of abiraterone acetate and niraparib, and methods of treatment of prostate cancer with said combinations.

Saved in:
Bibliographic Details
Main Authors TAMBWEKAR, KAUSTUBH RAMESH, DELAET, URBAIN ALFONS C, BERTELS, JOHNY, LOPEZ-GITLITZ, ANGELA, HARTMAN KOK, PAUL J A, HEYNS, PHILIP ERNA H, LUYTEN, KATRIEN, QUINTEN, THOMAS RONALD A, MARCOZZI, TATIANA
Format Patent
LanguageChinese
English
Published 01.03.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to a combination of abiraterone acetate and niraparib, free-dose and fixed-dose combinations of abiraterone acetate and niraparib, and methods of treatment of prostate cancer with said combinations.
Bibliography:Application Number: TW202110116509